Du, Y.; Fu, R.; Levinsky, J.T.; Kamalraj, P.; Chan, K.K.W.; Parmar, A.; Eskander, A.; Smoragiewicz, M.
Nivolumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Retrospective Tertiary Centre’s Real-World Experience. Curr. Oncol. 2023, 30, 8928-8935.
https://doi.org/10.3390/curroncol30100645
AMA Style
Du Y, Fu R, Levinsky JT, Kamalraj P, Chan KKW, Parmar A, Eskander A, Smoragiewicz M.
Nivolumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Retrospective Tertiary Centre’s Real-World Experience. Current Oncology. 2023; 30(10):8928-8935.
https://doi.org/10.3390/curroncol30100645
Chicago/Turabian Style
Du, Yue (Jennifer), Rui Fu, Justin T. Levinsky, Pabiththa Kamalraj, Kelvin K. W. Chan, Ambica Parmar, Antoine Eskander, and Martin Smoragiewicz.
2023. "Nivolumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Retrospective Tertiary Centre’s Real-World Experience" Current Oncology 30, no. 10: 8928-8935.
https://doi.org/10.3390/curroncol30100645
APA Style
Du, Y., Fu, R., Levinsky, J. T., Kamalraj, P., Chan, K. K. W., Parmar, A., Eskander, A., & Smoragiewicz, M.
(2023). Nivolumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Retrospective Tertiary Centre’s Real-World Experience. Current Oncology, 30(10), 8928-8935.
https://doi.org/10.3390/curroncol30100645
